Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance

Molecular Endocrinology

Volumn 15, Issue 9, 2001, Pages 1529-1538

  Ando, Shinichiro ^a   Sarlis, Nicholas J ^a   Krishnan, Jay ^a   Feng, Xu ^a   Refetoff, Samuel ^c   Zhang, Michael Q ^d   Oldfield, Edward H ^b   Yen, Paul M ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d Simons Center for Quantitative Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; MESSENGER RNA; THYROID HORMONE; THYROID HORMONE RECEPTOR; THYROTROPIN;

AGED; ALPHA CHAIN; ALTERNATIVE RNA SPLICING; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE DELETION; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE RESISTANCE; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; PRIORITY JOURNAL; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROTROPIN RELEASE;

EID: 0034837089     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.9.0687     Document Type: Article

References (58)

1. Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health
2. Thyrotropin-secreting pituitary tumors
3. Thyroid hormone receptors: Multiple forms, multiple possibilities
4. The molecular basis of thyroid hormone action
5. Nuclear receptor coregulators: Cellular and molecular biology
6. Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone
7. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone α gene by the thyroid hormone receptor
8. Structural and functional characterization of the genomic locus encoding the murine β2 thyroid hormone receptor
9. Differential and tissue-specific regulation of the multiple rat c-erbA mRNA species by thyroid hormone
10. Molecular basis of thyroid hormone-dependent brain development
11. Divergent roles for thyroid hormone receptor β isoforms in the endocrine axis and auditory system
12. The syndromes of resistance to thyroid hormone
13. Hormone receptor interactions in health and disease. Thyroid hormone resistance
14. Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health prospective study
15. A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin β-subunit gene
16. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone
17. RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression
18. Statistical features of human exons and their flanking regions
19. Identification of protein coding regions in the human genome by quadratic discriminant analysis
20. Resistance to thyroid hormone
21. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone
22. Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone
23. Novel insight from transgenic mice into thyroid hormone resistance and the regulation of thyrotropin
24. Selective pituitary resistance to thyroid hormone produced by expression of a mutant thyroid hormone receptor β gene in the pituitary gland of transgenic mice
25. Somatic mutation or aberrant alternative-splicing of thyroid hormone receptor beta can cause a defect in negative-regulation of thyrotropin in thyrotropin-secreting pituitary tumors
26. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors
27. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours
28. Screening of candidate oncogenes in human thyrotroph tumors: Absence of activating mutations of the G α q, G 11, G α s, or thyrotropin-releasing hormone receptor genes
29. A structural role for hormone in the thyroid hormone receptor
30. Molecular determinants of nuclear receptor-corepressor interaction
31. Mechanism of corepressor binding and release from nuclear hormone receptors
32. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
33. mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription
34. RNA processing and human disease
35. RNA splicing: What has phosphorylation got to do with it?
36. Aberrant splicing but not mutations of TSG101 in human breast cancer
37. Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer
38. Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
39. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis
40. Estrogen receptor variants in clinical breast cancer
41. Genetic and epigenetic alterations of the estrogen receptor gene and hormone independence in human breast cancer
42. A pituitary tumor in a patient with thyroid hormone resistance: A diagnostic dilemma
43. Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone
44. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation
45. Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor β gene
46. Mice deficient in the steroid receptor coactivator 1 (SRC-1) are resistant to thyroid hormone
47. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
48. Syndromes of glucocorticoid resistance
49. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets
50. Androgen insensitivity syndrome
51. Nephrogenic diabetes insipidus
52. Defects in G protein-coupled signal transduction in human disease
53. Mutant insulin receptors in syndromes of insulin resistance
54. Nuclear hormone receptors: From molecules to diseases
55. A new "new" syndrome in the new world: Is multiple postreceptor steroid hormone resistance due to a coregulator defect?
56. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system
57. Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary
58. Introducing a point mutation identified in a patient with pituitary resistance to thyroid hormone (Arg 338 to Trp) into other mutant thyroid hormone receptors weakens their dominant negative activities